Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 866 entries
View as:

Post Marketing Observational Study (PMOS) to Assess Quality of Life in Swedish Hidradenitis Suppurativa (HS) Patients

Phase: N/A Priority: Normal
NCT ID: NCT02739828 Org: User:
Start: 04/07/16 End: 03/28/18 Due: 03/28/19

A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Genotype 2 Chronic Hepatitis C Virus Infection

Phase: N/A Priority: Normal
NCT ID: NCT02723084 Org: User:
Start: 04/08/16 End: 03/24/17 Due: 03/24/18

Real World Study of Oral Upadacitinib Tablets to Assess Adverse Events and Change in Disease Activity in Adolescent and Adult Chinese Participants With Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT05959083 Org: User:
Start: 08/18/23 End: 06/30/26 Due: 06/30/27

Study of Oral Venetoclax Tablets to Evaluate Adverse Events and Change in Disease Activity in Participants Above 19 Years of Age With Acute Myeloid Leukemia (AML)

Phase: N/A Priority: Normal
NCT ID: NCT04826523 Org: User:
Start: 04/05/21 End: 11/30/25 Due: 11/30/26

Study in Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA) Patients to Evaluate Work Productivity Before and After the Start of Adalimumab Therapy in Daily Practice in Belgium

Phase: N/A Priority: Normal
NCT ID: NCT01845818 Org: User:
Start: 06/05/13 End: 06/23/17 Due: 06/23/18

Open Label Study to Evaluate Long Term Efficacy, Safety and Tolerability of Repeated Dosing in Subjects With Crohn's Disease and Who Participated and Successfully Completed M14-115

Phase: N/A Priority: Normal
NCT ID: NCT02185014 Org: User:
Start: 08/12/14 End: 11/03/17 Due: 11/03/18

Study Evaluate the PK Profile of Dalbavancin in Infants and Neonates Patients With Known or Suspected Bacterial Infection

Phase: N/A Priority: Normal
NCT ID: NCT02688790 Org: User:
Start: 04/01/16 End: 04/03/19 Due: 04/03/20

A Cariprazine Study in the Prevention of Relapse in Bipolar I Disorder Patients Whose Current Episode is Manic or Depressive, With or Without Mixed Features

Phase: N/A Priority: Normal
NCT ID: NCT03573297 Org: User:
Start: 06/15/18 End: 09/05/22 Due: 09/05/23

A Study Evaluating the Efficacy of Venetoclax Plus Ibrutinib in Participants With T-cell Prolymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT03873493 Org: User:
Start: 01/14/20 End: 11/04/21 Due: 11/04/22

Study To Assess Adverse Events and Drug to Drug Interaction of Oral Tablet Atogepant and Ubrogepant in Adult Participants With a History of Migraine

Phase: N/A Priority: Normal
NCT ID: NCT04818515 Org: User:
Start: 03/17/21 End: 06/18/21 Due: 06/18/22

Study to Assess Adverse Events and the Movement of Oral Venetoclax Tablet Through the Body of Female Participants Aged 18-75 Years With Impaired Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT04810598 Org: User:
Start: 07/08/21 End: 08/16/22 Due: 08/16/23

Study of Oral Atogepant Tablets to Assess Safety and Efficacy in Adult Participants With Migraine

Phase: N/A Priority: Normal
NCT ID: NCT06241313 Org: User:
Start: 03/25/24 End: 11/30/25 Due: 11/30/26

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT06890338 Org: User:
Start: 07/28/25 End: 10/31/29 Due: 10/31/30

A Study to Assess Adverse Events and Change in Disease Activity of Intramuscular AGN-151586 Injection in Adult Participants With Glabellar Lines

Phase: N/A Priority: Normal
NCT ID: NCT05248867 Org: User:
Start: 03/16/22 End: 03/17/23 Due: 03/17/24

A Study to Assess Multiple Ascending Dose, Drug-Drug Interaction, and Asian Pharmacokinetic Study of ABBV-1088

Phase: N/A Priority: Normal
NCT ID: NCT06579300 Org: User:
Start: 09/04/24 End: 11/30/25 Due: 11/30/26

A Study of ABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02988960 Org: User:
Start: 02/22/17 End: 09/30/25 Due: 09/30/26

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

Phase: N/A Priority: Normal
NCT ID: NCT01329380 Org: User:
Start: 10/27/10 End: 12/28/17 Due: 12/28/18

A Study of Venetoclax in Combination With Low Dose Cytarabine Versus Low Dose Cytarabine Alone in Treatment Naive Patients With Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT03069352 Org: User:
Start: 05/23/17 End: 07/18/25 Due: 07/18/26

A Study to Evaluate Participant Satisfaction and Natural Outcomes Following Administration of BOTOX Cosmetic Injections in Adult Participants for Treatment of Upper Facial Lines

Phase: N/A Priority: Normal
NCT ID: NCT06218251 Org: User:
Start: 02/05/24 End: 12/17/24 Due: 12/17/25

A Study to Assess the Safety and Effectiveness of Palivizumab Administered to Children at High Risk of Severe Respiratory Syncytial Virus (RSV) Infection in the Russian Federation and the Republic of Belarus

Phase: N/A Priority: Normal
NCT ID: NCT02968173 Org: User:
Start: 11/09/16 End: 07/13/17 Due: 07/13/18

A Study of of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus (HCV) Genotype 5 or 6 Infection

Phase: N/A Priority: Normal
NCT ID: NCT02966795 Org: User:
Start: 01/25/17 End: 08/29/18 Due: 08/29/19

A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug

Phase: N/A Priority: Normal
NCT ID: NCT03104374 Org: User:
Start: 05/01/17 End: 09/30/24 Due: 09/30/25

A Study of the Effectiveness of Venetoclax Tablets in Adult Acute Myeloid Leukemia Participants Ineligible for Standard Induction Therapy in Russian Federation

Phase: N/A Priority: Normal
NCT ID: NCT04253314 Org: User:
Start: 03/13/20 End: 02/16/23 Due: 02/16/24

A Study of Oral Upadacitinib Tablets to Assess Change in Disease State in Participants Aged 12-75 Years With Moderate to Severe Atopic Dermatitis in Brazil

Phase: N/A Priority: Normal
NCT ID: NCT04666675 Org: User:
Start: 12/24/20 End: 03/23/21 Due: 03/23/22

Study to Evaluate Adverse Events and Change in Disease Activity in Adult and Adolescent Participants With Acute Hepatitis C Virus (HCV) Infection on Treatment With Oral Tablets of Glecaprevir (GLE)/Pibrentasvir (PIB)

Phase: N/A Priority: Normal
NCT ID: NCT04903626 Org: User:
Start: 08/24/21 End: 09/17/24 Due: 09/17/25